FIN-10423, Sherman Oaks, CA — Sherman Oaks, California

FIN-10423, Sherman Oaks, CA is a clinical research site located in Sherman Oaks, California, United States 91403.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

FIN-10423, Sherman Oaks, CA has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Heart Failure.

Sponsors: Colorado Prevention Center.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sherman Oaks

Browse all research sites in California · View every site in Sherman Oaks

• University of California Davis Medical Center ( Site 1064)
• California Neuroscience Research Medical Group
• Schuster Medical Research Institute
• Research Site
• California Neuroscience Research
• Unison Clinical Trials
• GSK Investigational Site
• Clinical Research Site
• Cura Clinical Research
• Clinical Site
• Skyline Urology
• Shahram Jacobs MD Inc

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for FIN-10423, Sherman Oaks, CA?

FIN-10423, Sherman Oaks, CA has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has FIN-10423, Sherman Oaks, CA conducted?

FIN-10423, Sherman Oaks, CA has 1 clinical trials on record, with 1 currently active. Their work covers Heart Failure.

Is FIN-10423, Sherman Oaks, CA accredited by Crixeo Clinical Trials?

FIN-10423, Sherman Oaks, CA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about FIN-10423, Sherman Oaks, CA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.